Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes

This study has been completed.
Information provided by (Responsible Party):
Mesoblast, Ltd. Identifier:
First received: April 9, 2012
Last updated: October 12, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):